...

Module

New Data on Currently Available HCV Therapies and Their Impact on Initial Treatment Strategies

Source: Hepatitis Annual Update 2008

New Data on Currently Available HCV Therapies and Their Impact on Initial Treatment Strategies


Co-Chair: Raymond T. Chung, MD

Faculty:

Mark S. Sulkowski, MD
  • Mark S. Sulkowski, MD

CREDIT INFORMATION

Release Date: 07/07/08

Expiration Date: 07/06/09


Physicians: maximum of 1.0 AMA PRA Category 1 Credit

Registered Nurses: 1.0 Nursing contact hour

Pharmacists: 1.0 contact hour (0.1 CEUs)

Status: Please log in to view status


Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the use of viral kinetic principles to determine duration of initial therapy
  • Summarize initial treatment of hepatitis C for special, difficult-to-treat populations
  • Describe strategies for tailoring and individualizing initial therapy in hepatitis C

Topics covered include:

  • Introduction
  • Managing Pretreatment Factors
  • Modifiable Treatment Factors
  • Conclusions
  • Summary: Implications for Clinical Practice


Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grants provided by:

Educational grants support only the CME-certified components of this program.